{"name":"Paradigm Biopharmaceuticals USA (INC)","slug":"paradigm-biopharmaceuticals-usa-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxOdWVQWjhWbHdsWmJPZTFMMnh6czBsOThDZEpmZHQ0ODZWMkh5VmpwOWdESzlOZGZnTkxmNTM2eXQwREFJS2tPOGh5U3hpM3M3Y1pnTUxEQWQzSkZGRnJYUVpLSHdySWhHR2FsZkpfUGlnV1JmUXY4UnZvMXdvWlA3RGtGSHF3TUg2alhRaDBERFdCTXFRVWR5RlFTRS02QUpHZkFJQVNXWnpXeWQyZ0hTeC00d3E4NjZxZW44?oc=5","date":"2025-12-04","type":"deal","source":"Fierce Biotech","summary":"Paradigm Health raises $78M to revamp clinical research process, inks deal with Roche's Flatiron - Fierce Biotech","headline":"Paradigm Health raises $78M to revamp clinical research process, inks deal with Roche's Flatiron","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-10-23","type":"pipeline","source":"simplywall.st","summary":"Paradigm Biopharmaceuticals (ASX:PAR): Assessing Valuation as Investor Focus Builds Ahead of Ignite Summit Presentation - simplywall.st","headline":"Paradigm Biopharmaceuticals (ASX:PAR): Assessing Valuation as Investor Focus Builds Ahead of Ignite Summit Presentation","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE9xVF9JN1BHamxCZjUzV3dxU3hrLXBNb0QwT2s4eUpzUzBjLWpsMGxpRUxkbjRoaWNhU0NpNnA5MUk3UVhQckYzR3hFOEJ3MGxmVlBj?oc=5","date":"2025-10-21","type":"patent","source":"Stocks Down Under","summary":"There's a US$180bn Biotech Patent Cliff coming! Here's why it could spell doom for large caps, but a generational opportunity for small caps - Stocks Down Under","headline":"There's a US$180bn Biotech Patent Cliff coming! Here's why it could spell doom for large caps, but a generational opport","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxOZTZJemt5T3Y1eW5uV0M4QVFIWWRtY1FsYjg0RTFuWHhkT2syT2tJUEEyMWJhLWVydGtYMDdWeVNOTS05R0lscWJqYi1BMzhGNGpxelVpTWxWVTdfSmRBNlg4dlF2YTFCVFZmNmdoaVBLMExvem5yRXVWTkVzUUJRS2VlRjV6VUpHRmN3ak12T216RjRm?oc=5","date":"2025-10-01","type":"earnings","source":"Yahoo Finance","summary":"Paradigm Biopharmaceuticals Limited's (ASX:PAR) Profit Outlook - Yahoo Finance","headline":"Paradigm Biopharmaceuticals Limited's (ASX:PAR) Profit Outlook","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxQSHItQWZjeXF4NWxPdEZ4LVFlQmhvQW5zdklvWEFNQnpYYUhpSkFMdFJIcTY1LW1ycUxsbzZVQXh6TWpYSWg0WHBRY1NxOEhfUThmbDdKRDVjT0xFSk45VTBsSEZJci1sbUVvWmZCQk1zaFhkNHRmeUVOYlM5Z3Q4Y0tnMklCSGFUVnNybzhQeUc0bzMwRlRPRDVzdXI4S01sU0lPVkw1VEN0YWhZVnZZT2Q4VTNPZUFtcVZlVA?oc=5","date":"2025-08-31","type":"trial","source":"Biotech Dispatch","summary":"Paradigm Biopharmaceuticals enters critical phase with global osteoarthritis program - Biotech Dispatch","headline":"Paradigm Biopharmaceuticals enters critical phase with global osteoarthritis program","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-06-18","type":"pipeline","source":"PR Newswire","summary":"Paradigm Therapeutics, Inc. Announces an Additional Investment by Eshelman Ventures, LLC to Expedite Global Development and Global Registration of SD-101, A Topical Therapy for Treatment Across the En","headline":"Paradigm Therapeutics, Inc. Announces an Additional Investment by Eshelman Ventures, LLC to Expedite Global Development ","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-05-07","type":"pipeline","source":"BioSpace","summary":"Paradigm Therapeutics, Inc. Announces Investment by Eshelman Ventures, LLC to Support Completion of Development of SD-101 (Zorblisa™), A Topical Therapy for Treatment Across the Entire Skin Surface of","headline":"Paradigm Therapeutics, Inc. Announces Investment by Eshelman Ventures, LLC to Support Completion of Development of SD-10","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxNcGNkNGdscjhsMkpUeW9GbWQzTW1GcktTd003SFYzVlRmMC1EMThUc1dtdk8xcVNLV1Z2UGhTWkRQdm1SdGh1NENNaHg1azB3cGltc0ozWjlCSWROc2RMU2g0MG5hNEdRalFmdVNick9ELVliczRodklzelJYdXVxZ0NQcWFiVmRuTktvX0JDRQ?oc=5","date":"2025-03-29","type":"pipeline","source":"Yahoo Finance","summary":"Is Paradigm Biopharmaceuticals (ASX:PAR) In A Good Position To Invest In Growth? - Yahoo Finance","headline":"Is Paradigm Biopharmaceuticals (ASX:PAR) In A Good Position To Invest In Growth?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxPTmY2bWh1WEpRSzhwb1NIczZseVpzbFp5ZHpMWGpjRlFaMUlfc0R0Q3otdzlaMzV4dnE2Q0RPdU1RTG54dy1DT1ZhUldZeXJ3ZnZzRUpoQVNYeDhBYlBzMWNOVjBQUTg3MFZMNWl5dV9uT3BQN3JsSi00YkVYUWNISnZjU053dmRkbXlLc1dpU3F2T1FMeFIweUZWLWNRTW9Namx6V2tvZTFMdw?oc=5","date":"2024-07-26","type":"pipeline","source":"intelligentinvestor.com.au","summary":"Paradigm Biopharmaceuticals: The Path Forward - intelligentinvestor.com.au","headline":"Paradigm Biopharmaceuticals: The Path Forward","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxPS2NzTlVHMkVJT2lvc0U0UDJMTVZxbzZjQkNnX0JxRDlHYXducE1GT0h3UWdVWDhhSmlxU2JfTXFkS2pFUk9YeXA4U3JGX0V2RmxTSF9pRWk2WVRBd1Q3eWdrekZxNHJSeXlGUkt1VEtmRkQtb3JFODd1bVMzc3QzQ21SVEtqUHh1VjhEc3JjZW9KZkJMbHBkVElFYV8?oc=5","date":"2022-06-27","type":"pipeline","source":"citybiz","summary":"Paradigm Biopharmaceuticals Appoints Marco Polizzi as CEO - citybiz","headline":"Paradigm Biopharmaceuticals Appoints Marco Polizzi as CEO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8wFBVV95cUxOSGFwQXhadGY2WGtLbHA3OGE5a3lxc1RHVWoyYmhETVEwc2hSZGN4aVpBRTBRdWs0MXZzRGpKczYzU09rZ1AwMzA3WkJHM3Z1WFJSbDlCbllEQklzOEI5QnByVEFtcnlySVdvaEIwOXhWSHFRUkwwVG1iUE9KbkxLcG4tT3NwWkJlUzU4dmxEdk40OE1HZVI2UkhQU21wWGVubElJYV84NHBZaEZrX1RBeTZMelJfRnFRRUhrZUNfYzRvdEFycUo1SFhfdHFGYUVGSl85RW5JODBqOHl3OGwwaG1URlJGQ3k1YjhwN21VcU5BeE0?oc=5","date":"2022-05-29","type":"pipeline","source":"proactiveinvestors.com","summary":"Paradigm Biopharmaceuticals targets growth with appointment of US-based Marco Polizzi as CEO - proactiveinvestors.com","headline":"Paradigm Biopharmaceuticals targets growth with appointment of US-based Marco Polizzi as CEO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxNNklyak1sdlByQzZ4OEZ1bEcyc1V6N2tvOXpvV2FoUGlnc0kyejRQVHMyNDM5bFdSTUR1ZUxoSlRvUDBia05qb1VaRkgyTzFWYWFLVmRjeHBsOGtzVjFhUGV3eXBhLWJSSFZZcFhvYkFvNnhXSldkamtJYVpKYUUyQzhCVnVMbHJsZ1psdTc5aFpRYkExb1d6QVFQaDg4VlhjZ2dDVGtrNDBjN0pTM2QtOExYMEZLeS13VUs5UXdhSUg?oc=5","date":"2021-12-02","type":"pipeline","source":"McKinsey & Company","summary":"Integrated evidence generation: A paradigm shift in biopharma - McKinsey & Company","headline":"Integrated evidence generation: A paradigm shift in biopharma - McKinsey & Company","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}